113 related articles for article (PubMed ID: 30129224)
1. Solving the riddle: Unraveling the mechanisms of blocking the binding of leukotoxin by therapeutic antagonists in periodontal diseases.
Abdullahi M; Olotu FA; Soliman ME
J Cell Biochem; 2018 Nov; 119(11):9364-9379. PubMed ID: 30129224
[TBL] [Abstract][Full Text] [Related]
2.
Vega BA; Belinka BA; Kachlany SC
Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31454891
[No Abstract] [Full Text] [Related]
3. Receptor-Based Peptides for Inhibition of Leukotoxin Activity.
Krueger E; Hayes S; Chang EH; Yutuc S; Brown AC
ACS Infect Dis; 2018 Jul; 4(7):1073-1081. PubMed ID: 29742342
[TBL] [Abstract][Full Text] [Related]
4. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes.
Kaur M; Kachlany SC
Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107
[TBL] [Abstract][Full Text] [Related]
5. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
[TBL] [Abstract][Full Text] [Related]
6. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin.
Dileepan T; Kachlany SC; Balashova NV; Patel J; Maheswaran SK
Infect Immun; 2007 Oct; 75(10):4851-6. PubMed ID: 17635865
[TBL] [Abstract][Full Text] [Related]
7. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
8.
Nice JB; Balashova NV; Kachlany SC; Koufos E; Krueger E; Lally ET; Brown AC
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322160
[TBL] [Abstract][Full Text] [Related]
9. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
[TBL] [Abstract][Full Text] [Related]
10. Aggregatibacter actinomycetemcomitans induces detachment and death of human gingival epithelial cells and fibroblasts via elastase release following leukotoxin-dependent neutrophil lysis.
Hiyoshi T; Domon H; Maekawa T; Nagai K; Tamura H; Takahashi N; Yonezawa D; Miyoshi T; Yoshida A; Tabeta K; Terao Y
Microbiol Immunol; 2019 Mar; 63(3-4):100-110. PubMed ID: 30817027
[TBL] [Abstract][Full Text] [Related]
11. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
[TBL] [Abstract][Full Text] [Related]
12. Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.
Krueger E; Brown AC
Mol Oral Microbiol; 2020 Jun; 35(3):85-105. PubMed ID: 32061022
[TBL] [Abstract][Full Text] [Related]
13. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association.
Brown AC; Balashova NV; Epand RM; Epand RF; Bragin A; Kachlany SC; Walters MJ; Du Y; Boesze-Battaglia K; Lally ET
J Biol Chem; 2013 Aug; 288(32):23607-21. PubMed ID: 23792963
[TBL] [Abstract][Full Text] [Related]
14. Cranberry Proanthocyanidins Neutralize the Effects of
Ben Lagha A; Howell A; Grenier D
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
[No Abstract] [Full Text] [Related]
15. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
Reinholdt J; Poulsen K; Brinkmann CR; Hoffmann SV; Stapulionis R; Enghild JJ; Jensen UB; Boesen T; Vorup-Jensen T
Biochim Biophys Acta; 2013 Feb; 1834(2):546-58. PubMed ID: 23234758
[TBL] [Abstract][Full Text] [Related]
16. Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans.
Childress C; Feuerbacher LA; Phillips L; Burgum A; Kolodrubetz D
J Bacteriol; 2013 May; 195(10):2284-97. PubMed ID: 23475968
[TBL] [Abstract][Full Text] [Related]
17. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.
DiFranco KM; Johnson-Farley N; Bertino JR; Elson D; Vega BA; Belinka BA; Kachlany SC
Leuk Res; 2015 Jun; 39(6):649-56. PubMed ID: 25850729
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.
Forman MS; Nishikubo JB; Han RK; Le A; Balashova NV; Kachlany SC
Toxins (Basel); 2010 Dec; 2(12):2824-36. PubMed ID: 22069577
[TBL] [Abstract][Full Text] [Related]
19. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells.
Balashova NV; Shah C; Patel JK; Megalla S; Kachlany SC
Gene; 2009 Aug; 443(1-2):42-7. PubMed ID: 19450669
[TBL] [Abstract][Full Text] [Related]
20. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
Johansson A
Toxins (Basel); 2011 Mar; 3(3):242-59. PubMed ID: 22069708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
